NEW
HAVEN, Conn. and MONMOUTH
JUNCTION, N.J., June 19,
2024 /PRNewswire/ -- DiamiR, a developer of
innovative blood-based diagnostic tests for brain health and other
diseases, today announced that it will present a poster at the
Alzheimer's Association International Conference (AAIC), taking
place July 28th – Aug 1st, 2024, in Philadelphia, PA, and online.
Poster #95519 titled "Classifier algorithms to
characterize various stages of Alzheimer's disease based on
analysis of circulating brain-enriched and inflammation-associated
microRNAs" will be presented on Monday, July 29, 2024:
8:00 AM – 4:15
PM EDT, in the Pennsylvania Convention Center, Exhibit Hall
as part of AAIC's session titled "Developing Topics:
Biomarkers."
The company will also host booth, #1431, in the Exhibit Hall
during the conference to highlight its targeted approach aimed at
early detection and risk assessment of neurodegenerative diseases
and discuss collaborative opportunities.
About Alzheimer's Association International
Conference
The AAIC is the world's largest gathering dedicated to advancing
dementia science. Each year, AAIC convenes the world's leading
basic scientists, clinical researchers, early career investigators,
clinicians and the care research community to share breaking
research discoveries that are expected to lead to methods of
prevention and treatment and improvements in diagnosis for
Alzheimer's disease.
About DiamiR
DiamiR is a privately held molecular diagnostics company focused
on developing minimally invasive tests for detection and monitoring
of pathology based on quantitative analysis of organ-enriched
microRNA signatures in plasma for screening, patient
stratification, as well as disease progression and treatment
monitoring. DiamiR collaborates with leading academic centers,
disease foundations, and biopharma companies. For more information,
please visit the company's website at www.diamirbio.com.
This news release contains forward-looking statements regarding
future events. These statements are predictions and are subject to
risks and uncertainties that could cause the actual events or
results to differ materially.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such an
offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
Contact:
Alidad Mireskandari, PhD
203-570-8275
amireskandari@diamirbio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/diamir-biosciences-announces-poster-presentation-at-2024-alzheimers-association-international-conference-aaic-302176323.html
SOURCE DiamiR